RenaissanceRe Holdings Ltd. (NYSE:RNR – Free Report) – Equities research analysts at Zacks Research reduced their Q1 2025 earnings per share estimates for shares of RenaissanceRe in a report issued on Monday, February 10th. Zacks Research analyst K. Dey now expects that the insurance provider will earn $1.77 per share for the quarter, down from their previous estimate of $10.90. The consensus estimate for RenaissanceRe’s current full-year earnings is $29.92 per share. Zacks Research also issued estimates for RenaissanceRe’s Q2 2025 earnings at $11.07 EPS, Q3 2025 earnings at $3.85 EPS, FY2025 earnings at $25.41 EPS, Q1 2026 earnings at $7.77 EPS, Q2 2026 earnings at $12.03 EPS, Q3 2026 earnings at $8.41 EPS, FY2026 earnings at $38.64 EPS and FY2027 earnings at $41.10 EPS.
Several other brokerages have also recently weighed in on RNR. Evercore ISI lifted their price target on RenaissanceRe from $229.00 to $246.00 and gave the company an “underperform” rating in a research report on Thursday, November 7th. StockNews.com cut RenaissanceRe from a “buy” rating to a “hold” rating in a research report on Tuesday, October 22nd. Morgan Stanley cut their price objective on shares of RenaissanceRe from $265.00 to $245.00 and set an “equal weight” rating for the company in a research report on Friday, January 31st. Barclays lowered shares of RenaissanceRe from an “equal weight” rating to an “underweight” rating and decreased their target price for the stock from $284.00 to $234.00 in a report on Monday, January 6th. Finally, JPMorgan Chase & Co. raised their price target on shares of RenaissanceRe from $280.00 to $284.00 and gave the company a “neutral” rating in a report on Friday, January 3rd. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, RenaissanceRe currently has a consensus rating of “Hold” and a consensus target price of $279.90.
RenaissanceRe Trading Down 1.7 %
Shares of RNR stock opened at $230.93 on Thursday. The stock has a market capitalization of $11.99 billion, a price-to-earnings ratio of 6.59, a PEG ratio of 1.91 and a beta of 0.43. The company’s fifty day simple moving average is $251.89 and its two-hundred day simple moving average is $257.91. RenaissanceRe has a 1 year low of $208.98 and a 1 year high of $300.00. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.42 and a quick ratio of 1.43.
RenaissanceRe (NYSE:RNR – Get Free Report) last posted its quarterly earnings results on Tuesday, January 28th. The insurance provider reported $8.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.94 by $1.12. RenaissanceRe had a net margin of 15.99% and a return on equity of 23.41%.
Institutional Trading of RenaissanceRe
Hedge funds and other institutional investors have recently modified their holdings of the business. SBI Securities Co. Ltd. purchased a new position in shares of RenaissanceRe during the fourth quarter valued at approximately $29,000. ORG Wealth Partners LLC purchased a new stake in shares of RenaissanceRe in the third quarter worth $30,000. MassMutual Private Wealth & Trust FSB increased its holdings in shares of RenaissanceRe by 51.3% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 121 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 41 shares in the last quarter. UMB Bank n.a. boosted its stake in RenaissanceRe by 316.7% in the 3rd quarter. UMB Bank n.a. now owns 125 shares of the insurance provider’s stock worth $34,000 after purchasing an additional 95 shares in the last quarter. Finally, Jones Financial Companies Lllp grew its position in RenaissanceRe by 1,587.5% during the 4th quarter. Jones Financial Companies Lllp now owns 135 shares of the insurance provider’s stock valued at $34,000 after purchasing an additional 127 shares during the last quarter. 99.97% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other RenaissanceRe news, EVP David E. Marra sold 1,000 shares of the business’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $254.16, for a total value of $254,160.00. Following the transaction, the executive vice president now owns 79,392 shares in the company, valued at approximately $20,178,270.72. The trade was a 1.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is owned by insiders.
RenaissanceRe Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be issued a $0.40 dividend. This is a boost from RenaissanceRe’s previous quarterly dividend of $0.39. The ex-dividend date is Friday, March 14th. This represents a $1.60 annualized dividend and a dividend yield of 0.69%. RenaissanceRe’s dividend payout ratio (DPR) is currently 4.45%.
RenaissanceRe Company Profile
RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S.
Featured Stories
- Five stocks we like better than RenaissanceRe
- Best Aerospace Stocks Investing
- PayPal: Time to Strike With Shares Down Double Digits?
- What is a support level?
- Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins
- ESG Stocks, What Investors Should Know
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
Receive News & Ratings for RenaissanceRe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenaissanceRe and related companies with MarketBeat.com's FREE daily email newsletter.